J2507 Pegloticase injection
J-Codes
Also known as: pegloticase, krystexxa
Injection of pegloticase (Krystexxa), a recombinant uric acid-specific enzyme used to reduce serum uric acid in patients with refractory chronic gout.
Clinical Context
Administered intravenously for patients with severe, refractory gout unresponsive to conventional xanthine oxidase inhibitors and uricosuric agents.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.